#214 Responsiveness to roxadustat in non-dialysis chronic kidney disease patients with anemia by baseline iron status: a secondary analysis of the ROXSTAR registry
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.0446
Abstract: The ROXSTAR Registry (ChiCTR2100046322) is a phase 4, multicenter study conducted in China to evaluate the long-term safety and effectiveness of a 52-week roxadustat treatment in both dialysis and non-dialysis (ND) chronic kidney disease (CKD)… read more here.
Keywords: non absolute; iron; baseline iron; iron repletion ... See more keywords
A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and wellbeing.
Sign Up to like & getrecommendations! Published in 2022 at "Blood"
DOI: 10.1182/blood.2022017288
Abstract: Although altruistic regular blood donors are vital for the blood supply, many become iron deficient from donation-induced iron loss. The effects of blood donation-induced iron deficiency on red cell transfusion quality or donor cognition are… read more here.
Keywords: red cell; iron; iron repletion; blood ... See more keywords
Iron-induced NCOA4 condensation regulates ferritin fate and iron homeostasis.
Sign Up to like & getrecommendations! Published in 2022 at "EMBO reports"
DOI: 10.15252/embr.202154278
Abstract: Iron is not only essential but also a toxic trace element. Under iron repletion, ferritin maintains cellular iron homeostasis by storing iron to avoid iron toxicity. Under iron depletion, the ferritin-specific autophagy adaptor NCOA4 delivers… read more here.
Keywords: iron; fate iron; iron homeostasis; iron repletion ... See more keywords